Cargando…
Antispasmodic Drug Drofenine as an Inhibitor of Kv2.1 Channel Ameliorates Peripheral Neuropathy in Diabetic Mice
Diabetic peripheral neuropathy (DPN) is a common diabetic complication and has yet no efficient medication. Here, we report that antispasmodic drug drofenine (Dfe) blocks Kv2.1 and ameliorates DPN-like pathology in diabetic mice. The underlying mechanisms are investigated against the DPN mice with i...
Autores principales: | Xu, Xiaoju, Xu, Xu, Hao, Yanping, Zhu, Xialin, Lu, Jian, Ouyang, Xingnan, Lu, Yin, Huang, Xi, Li, Yang, Wang, Jiaying, Shen, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559245/ https://www.ncbi.nlm.nih.gov/pubmed/33089105 http://dx.doi.org/10.1016/j.isci.2020.101617 |
Ejemplares similares
-
SP6616 as a Kv2.1 inhibitor efficiently ameliorates peripheral neuropathy in diabetic mice
por: Zhu, Xialin, et al.
Publicado: (2020) -
Drofenine: a 2-APB analog with improved selectivity for human TRPV3
por: Deering-Rice, Cassandra E, et al.
Publicado: (2014) -
Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy
por: Kleinecke, Sandra, et al.
Publicado: (2017) -
Auxiliary KCNE subunits modulate both homotetrameric Kv2.1 and heterotetrameric Kv2.1/Kv6.4 channels
por: David, Jens-Peter, et al.
Publicado: (2015) -
Ipriflavone as a non‐steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice
por: Nie, Ruifang, et al.
Publicado: (2022)